LOX-PP–Hsp70–cRaf interactions resulted in reduced Erk1/2 signaling, which is Ras/c-Raf pathway-dependent, and consistent with the tumor growth inhibitory properties of LOX-PP. This evidence concerns the gene RAF1 and neoplasm.